Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.
CONCLUSION: Our findings help to delineate the clinical profile of patients with sJIA who are more likely to benefit from IL-1 blockade. They also underscore the need for studies aimed at examining the therapeutic role of early IL-1 inhibition and to identify biomarkers predicting response to either IL-1 or IL-6 antagonists.
PMID: 30647180 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Saccomanno B, Tibaldi J, Minoia F, Bagnasco F, Pistorio A, Guariento A, Caorsi R, Consolaro A, Gattorno M, Ravelli A Tags: J Rheumatol Source Type: research
More News: Arthritis | Children | Corticosteroid Therapy | Laboratory Medicine | Rheumatology | Statistics | Study